Hwail Pharmaceutical Co.,Ltd. (KOSDAQ: 061250)

Hwail Pharmaceutical Co.,Ltd. Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Operating Revenue	107,875	111,519	106,130	96,103	94,166	91,833
Other Revenue	0	0	-	-	-	0
Revenue	107,875	111,519	106,130	96,103	94,166	91,833
Revenue Growth (YoY)	-4.84%	5.08%	10.43%	2.06%	2.54%	17.59%
Cost of Revenue	93,787	96,971	96,588	82,202	78,370	76,102
Gross Profit	14,087	14,547	9,542	13,901	15,796	15,730
Selling, General & Admin	7,118	7,229	6,685	6,973	8,465	7,213
Research & Development	392.29	390.58	429.7	565.5	661.9	528.84
Other Operating Expenses	111.72	124.61	211.35	157.54	129.55	93.25
Operating Expenses	11,806	12,320	7,590	9,235	10,229	8,101
Operating Income	2,282	2,227	1,952	4,666	5,566	7,629
Interest Expense	-627.83	-706.26	-745.17	-574.31	-721.11	-870.22
Interest & Investment Income	206.96	184.29	173.14	466.92	411.12	523.72
Earnings From Equity Investments	-1,861	-1,620	-	-	-	-
Currency Exchange Gain (Loss)	-131.36	148.73	53.5	15.89	-94.13	-16.55
Other Non Operating Income (Expenses)	-281.57	-405.9	-265.45	-174.51	279.29	122.63
EBT Excluding Unusual Items	-412.91	-172.05	1,168	4,400	5,442	7,389
Gain (Loss) on Sale of Assets	2,954	8,477	6,112	26.74	-142.02	-294.27
Asset Writedown	-100	-100	-	-18.7	-	-
Pretax Income	2,442	8,205	7,279	4,408	5,300	7,095
Income Tax Expense	516.61	1,824	1,826	276.37	1,090	2,034
Net Income	1,925	6,382	5,453	4,132	4,209	5,060
Net Income to Common	1,925	6,382	5,453	4,132	4,209	5,060
Net Income Growth	-80.84%	17.03%	31.98%	-1.85%	-16.81%	7.99%
Shares Outstanding (Basic)	41	41	41	41	40	33
Shares Outstanding (Diluted)	41	41	41	41	41	40
Shares Change (YoY)	0.15%	-0.06%	0.21%	-0.24%	1.64%	0.03%
EPS (Basic)	47.45	157.30	134.33	102.00	104.00	155.67
EPS (Diluted)	47.45	157.30	134.33	102.00	103.67	126.67
EPS Growth	-80.86%	17.10%	31.70%	-1.61%	-18.16%	7.95%
Free Cash Flow	10,786	9,169	-7,960	-4,195	-2,213	-6,717
Free Cash Flow Per Share	265.88	226.01	-196.09	-103.57	-54.50	-168.14
Dividend Per Share	50.000	50.000	-	-	-	-
Gross Margin	13.06%	13.04%	8.99%	14.46%	16.77%	17.13%
Operating Margin	2.12%	2.00%	1.84%	4.86%	5.91%	8.31%
Profit Margin	1.78%	5.72%	5.14%	4.30%	4.47%	5.51%
Free Cash Flow Margin	10.00%	8.22%	-7.50%	-4.37%	-2.35%	-7.31%
EBITDA	5,200	5,191	4,723	6,537	6,989	9,021
EBITDA Margin	4.82%	4.65%	4.45%	6.80%	7.42%	9.82%
D&A For EBITDA	2,918	2,964	2,772	1,871	1,422	1,392
EBIT	2,282	2,227	1,952	4,666	5,566	7,629
EBIT Margin	2.12%	2.00%	1.84%	4.86%	5.91%	8.31%
Effective Tax Rate	21.16%	22.23%	25.09%	6.27%	20.57%	28.68%
Advertising Expenses	-	42.67	12.09	33.09	17.32	33.5

Source: S&P Capital IQ. Standard template. Financial Sources.